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Abstract
Re-engineering the tropism of viruses is an attractive translational strategy for targeting cancer cells. The Ras signal
transduction pathway is a central hub for a variety of pro-oncogenic events with a fundamental role in normal and
neoplastic physiology. In this work we were interested in linking Ras activation to HSV-1 replication in a direct manner in
order to generate a novel oncolytic herpes virus which can target cancer cells. To establish such link, we developed a
mutant HSV-1 in which the expression of ICP4 (infected cell protein-4, a viral protein necessary for replication) is controlled
by activation of ELK, a transcription factor down-stream of the Ras pathway and mainly activated by ERK (extracellular
signal-regulated kinase, an important Ras effector pathway). This mutant HSV-1 was named as Signal-Smart 1 (SS1). A series
of prostate cells were infected with the SS1 virus. Cells with elevated levels of ELK activation were preferentially infected by
the SS1 virus, as demonstrated by increased levels of viral progeny, herpetic glycoprotein C and overall SS1 viral protein
production. Upon exposure to SS1, the proliferation, invasiveness and colony formation capabilities of prostate cancer cells
with increased ELK activation were significantly decreased (p,0.05), while the rate of apoptosis/necrosis in these cells was
increased. Additionally, high Ras signaling cells infected with SS1 showed a prominent arrest in the G1 phase of the cell
cycle as compared to cells exposed to parental HSV-1. The results of this study reveal the potential for re-modeling the host-
herpes interaction to specifically interfere with the life of cancer cells with increased Ras signaling. SS1 also serves as a
‘‘prototype’’ for development of a family of signal-smart viruses which can target cancer cells on the basis of their signaling
portfolio.
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Introduction
Ras is a major proto-oncogene involved in 35% of all human
cancers (Adjei, 2001). Ras activation results in stimulation of
different mitogen-activated protein kinases (MAPKs) [1,2,3,4].
MAPKs are involved in diverse cellular functions including cell
proliferation, cell cycle regulation, cell survival, angiogenesis, and
cell migration [1,5,6,7,8,9,10,11,12]. Different extracellular chem-
ical and physical signals can stimulate MAPKs making them an
important part of the machinery needed to transduce signals from
receptor to regulatory molecule inside the cell. Activation of the
Ras/Raf/ERK1/2 pathway results in the serine/threonine kinase
ERK1/2 phosphorylating, among other substrates, the nuclear
transcription factor, ELK [13,14]. ELK is a member of the Ets-
family and is a component of the ternary complex that mediates
gene activity in response to serum and growth factors. Phosphor-
ylated-ELK, in combination with serum response factor (SRF),
binds to an enhancer element in the c-fos promoter referred to as
serum response element (SRE) inducing the transcription of many
genes involved in biological functions such as proliferation and
differentiation [15,16].
We have shown previously that cells with overactivation of Ras
signaling are more permissive to infection by herpes simplex virus-
1 (HSV-1) due to the impaired action of double-stranded RNA-
induced protein kinase (PKR), the main host defense mechanism
against viral infection [17,18]. Here, we expand on these studies
by establishing a direct relationship between Ras signaling in host
cells and HSV-1 replication by developing a mutant HSV-1 which
is responsive at transcriptional level to Ras activation. Our goal
was to engineer the pathogenicity of the virus to only interfere with
host viability on the basis of overactivation of the Ras/ERK/ELK
pathway. This mutant virus is referred to as Signal-Smart 1 (SS1)
virus and was tested in a range of prostate cancer cells. Prostate
cancer has been tested before as a target for gene therapy using an
amplicon herpes system (containing a probasin-derived promoter)
to complement a replication defective mutant herpes[19]. In this
study we show that the SS1 virus preferentially infects prostate
cancer cells with increased ELK/SRE activation inducing changes
in viability, invasiveness, colony formation, cell cycle progression,
apoptosis and necrosis.
Results and Discussion
Construction of the mutant SS1 virus
The SS1 mutant virus contains one copy of the herpetic alpha-4
gene under the control of a synthetic promoter. This gene encodes
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6514the infected cell protein-4 (ICP4), which is a necessary protein for
viral replication. The synthetic promoter is composed of five
tandem repeats of SRE (the DNA binding element for ELK) and a
minimal TATA sequence. The 5xSRE-TATA-ICP4 sequence is
followed by an internal ribosome entry site (IRES) and the
fluorescent protein DsRed-express (Figure 1A). The SS1 virus was
produced by infecting E5 cells (expressing ICP4) with d120, a
mutant HSV-1 with deletions in both copies of the alpha-4 gene,
followed by transfection of d120-infected E5 cells with a plasmid
containing 5xSRE-ICP4-IRES-DsRed-express (pTSIIDT). The
5xSRE-ICP4-IRES-DsRed-express construct is flanked by two
complementary regions homologus to HSV-1 thymidine kinase
(TK). Once both d120 viral genomic DNA and pTSIIDT are
present within the E5 cells, homologus recombination with the TK
gene results in the insertion of 5xSRE-ICP4-IRES-DsRed-express
in the d120 genome and generation of the SS1 virus.
Figure 1B explains the results of PCR experiments on SS1 DNA
preparations. Six independent viral isolates (numbered 1–6) are
investigated with the purpose of confirming the structure of this
mutant virus. The structure of the recombinant promoter was
confirmed by performing PCR using primers which span over the
promoter (5xSRE-TATA) and cover a portion of the ICP4 gene.
In each case, the PCR product was sequenced and compared to
the related sequence in our database. Contamination of genomic
viral DNA preparations by pTSIIDT was ruled out by performing
PCR targeting the backbone areas of this plasmid. Following
Figure 1. Characteristics of Signal-Smart 1(SS1) mutant HSV-1. The SS1 virus contains one copy of ICP4 gene under the control of 5xSRE and
minimal TATA sequence. (A) Viral genomic PCR reactions confirm the structure of the recombinant ICP4 gene. The sequence for each pair of primer,
the relative positions and of the primers as well as their sequence and results are shown. The PCRs were performed on U87 cells (non-transfected),
d120-genomic DNA (labeled as d120) and the plasmid pTSIIDT. Performing PCR on back-bone elements of pTSIIDT is done in order to rule out the
contamination of genomic viral DNA preparations by pTSIIDT. (B) Genomic structure of HSV-1 and SS1 virus and pTSIIDT plasmid DNA. NotI
restriction analysis: The 9.3 Kb NotI fragment contains the plasmid backbone, the 2.8 and 0.7 Kb fragments are the expected digestion pattern from
both SS1 and pTSIIDT, which contains the ICP4 gene (arrowheads). Twenty mg DNA of each sample was digested over night at 37uC and resolved in
1% agarose gel. Lane 1:HSV-1/NotI; Lane 2:d120/NotI; Lane 3:SS1/NotI; Lane4: pTSIIDT/NotI; Lane5:DNA marker (from top to bottom: 23, 9.4, 6.6, 4.4,
2.3, 2.0 and 0.5 Kb).
doi:10.1371/journal.pone.0006514.g001
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was selected for further expansion to be used in the experiments.
Furthermore, the genomic DNA from d120, SS1 and HSV-1 were
analyzed by restriction digestion with NotI (Figure 1C, results
shown for NotI). The segment analysis by these restriction
endonucleases confirmed that the inserted gene sequences in
SS1 were structurally consistent with the plasmid, pTSIIDT and
that overall genomic structure of SS1 remains in harmony with
d120 and wild-type HSV-1. The SS1 virus was then amplified and
titrated with known methods [20].
Prostate cells contain different levels of Ras/ERK/ELK
activation
We next evaluated the level of Ras/ELK signaling in malignant
and non-malignant prostate cells. Phosphorylated ELK and
activation of SRE are both down-stream effectors of the Ras/
ERK/ELK pathway (Figure 2A). Levels of both effectors were
measured in several prostate cancer cell lines (PC3, C4, C4-2,
Du145, LapC4, LnCap, PC3-AR, PC3-Neo), primary prostate
epithelial cells (PrEC), benign prostate hyperplasic cells (BPH-1),
and human tissue samples. A higher level of phospho-ELK (P-
ELK) was seen for the prostate cancer cell lines LapC4 and LnCap
and the non-malignant cell lines BPH-1 and PrEC (Figure 2B,
band intensities are evaluated in comparison to the strongest band
which in this case was the band for PrEC represented as 100%,
ND stands for not detectable). For the rest of this study, we focused
on LapC4 and LnCap as high Ras signaling cancer cells, Du145
and PC3 as low Ras signaling cancer cells, along with PrEC and
BPH-1 cells. We next measured the binding of phospho-ELK to
SRE (as a representation of SRE activation) in these cells using a
Luminex based assay (Figure 2C). LnCap and LapC4 exhibited
higher levels of SRE activation than Du145 and PC3 cells. PrEC
and BPH-1 also showed increased SRE activation. It is important
Figure 2. Ras signaling and activation of ERK/ELK/SRE in prostate cells and tissue. Activation of Ras leads to initiation of a signal via Raf/
MEK/ERK which in turn phosphorylates/activates transcription factor ELK. ELK in combination with SRF drives expression from promoters containing
SRE elements. (A) Activation of ERK and phosphorylation of ELK in a series of prostate cells including prostate cancer cells, PrECs and BPH-1 is
evaluated by in-vitro kinase assay for P-ERK. Band intensities are evaluated in comparison to the strongest band which in this case was the band for
PrEC represented as 100%, ND stands for not detectable. (B) Activation of SRE by binding of P-ELK was evaluated by performing a Luminex-based
assay. Existence of P-ELK and its binding to SRE elements protects these oligomers from digestion by a nuclease and allows generation of light. (C)
Expression of P-ELK (active ELK) in malignant prostate tissue samples (n=10, average Gleason score 6.0) and non-malignant prostate tissue was
evaluated by performing immunohistochemistry and following image analysis for dark brown nuclear staining representing P-ELK using appropriate
software. Upper panels show a sample of P-ELK staining for tumoral and normal tissues while the lower panels show average of staining intensity for
P-ELK in different samples.
doi:10.1371/journal.pone.0006514.g002
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generated by ERK-pathway, figure 2C provides us with activation
levels of SRE in these cells. Although ERK is the major
contributor to ELK phosphorylation, other pathways might also
induce ELK and therefore, at least partly, contribute to SRE
activation shown in figure 2C. In any case, LnCap, LapC4, BPH-1
and PrEC on both assays exhibit higher levels of activation than
Du145 and PC3.
Given that PrECs showed higher levels of phospho-ELK than
any of the prostate cancer cell lines, we wanted to determine if this
finding was in harmony with phospho-ELK levels in tumoral and
normal prostate tissues. To achieve this, the levels of phospho-
ELK activation in prostate tissues were compared in tumoral
(n=10, average Gleason score over 6.0) and non-tumoral (n=10)
samples with immunohistochemistry using an antibody specific for
phospho-ELK. Dark brown staining in nucleus represents
phospho-ELK and was quantified by scanning slides using related
software. Levels of phospho-ELK were significantly lower in
normal tissue samples as compared to malignant samples
(Figure 2D) (p,0.05). Therefore, although PrECs show elevated
levels of ELK activation, normal prostate tissue remains
significantly lower in this regards as compared to tumoral tissue.
These results confirm that a major difference exists between
information obtained from cultured cells in- vitro and analysis of
tumoral tissues.
Prostate cells with elevated levels of ELK/SRE activation
are more permissive to SS1 virus
In order to understand the effect of high and low Ras signaling
on permissiveness, we infected prostate cancer cells and non-
malignant PrECs and BPH-1 cells with SS1 and parental HSV-1
virus at a multiplicity of infection of 1 (MOI,1). A variety of
techniques including titration of viral progeny, immmunoflour-
escent (IF) studies on envelope glycoprotein C (gC, an standard
marker for herpetic infection) and western blotting for herpes
proteins were used to evaluate and compare the permissiveness of
these cells. Morphological studies of SS1-infected cells showed a
more prominent pattern of infection (rounding and clumping) for
LnCap, LapC4, PrEC and BPH-1 as compared with Du145 and
PC3 cells (Figure 3A). Levels of SS1 progeny virus detected upon
infection of LapC4 and LnCap (high Ras cancer cells) were higher
than Du145 and PC3 (low Ras cancer cells) (Figure 3B). PrECs
and BPH-1 also produced elevated levels of viral progeny because
of their elevated ELK activation as mentioned before. In case of
HSV-1, however, progeny virus levels were found to be
comparable in all cells at 48 hours post-infection (Figure 3B lower
panel). Another level of evidence for the enhanced capability of
SS1 to target cells with increased Ras/ELK signaling was obtained
by studying these cells for expression levels of gC. Although HSV-
1 infected LapC4 and Du145 with comparable intensity, LapC4
cells were remarkably more permissive to the SS1 virus in
comparison to Du145 (Figure 3C). Lower panel shows staining of
uninfected LapC4 cells with anti-gC antibody in order to prove its
specificity for infected cells (Texas red is the background stain of
the anti-gC antibody preparation and serves to visualize the cell
monolayer).
Finally, evaluating expression of a series of herpetic proteins in
these cells by western blotting for viral proteins (Figure 3D)
revealed enhanced and comprehensive protein expression in
PrECs, BPH1, LapC4 and LnCap as compared to minimal levels
of viral protein synthesis for Du145 and PC3 cells (all bands show
herpetic proteins). If replication of SS1 is dependent on Ras
signaling, it would be rational to expect that inhibitors of this
pathway would reduce the production of herpetic proteins and
therefore permissiveness to the virus. Indeed, once exposed to the
inhibitors of Ras signaling a reduction in the levels of SS1 protein
synthesis was observed for LnCap cells. The reducing effects of
EGFR inhibitor AG1478 (0.5 mg) was found to be lesser than
effects observed for FTI-276(blocker of Ras farnesylation used at
5 nm), PD98059 (blocker of MEK/ERK pathway used at 20 mM)
and Chromomycin A (a blocker of ELK binding to SRE used at
500 nM). Interestingly, the effects of Chromomycin A [21], was
found to be the strongest providing further evidence for
dependency of SS1 virus on transcriptional activity of ELK. All
of these data show the capability of the SS1 virus to preferentially
target cells with elevated Ras/ELK signaling. To this end, it is
important to note that PrEC cells, although not transformed but
containing enhanced levels of ELK/SRE activation, were not
found to be immune to the effects of the virus. We attribute such a
phenomenon to the altered signaling characteristics of primary
cells once cultured in vitro. This claim is supported by the
significantly lower levels of ELK activation in normal prostate
tissue as compared to tumoral samples (Figure 1D).
Prostate cells with elevated levels of ELK/SRE activation
were less viable and invasive upon exposure to SS1 virus
In next step we studied the biological outcome of exposing
prostate cells to SS1 virus (MOI,1). The proliferation rate of
prostate cells was measured at 24 and 48 hours post-infection and
compared to uninfected controls. As in figure 4A, once exposed to
the SS1 virus, the proliferation rate of cells with elevated Ras/
ELK signaling is more prominently reduced as compared with
cancer cells with lower Ras/ELK signaling (p,0.05).
The effects of SS1 infection on invasiveness of prostate cancer
cells was also studied by testing the capabilities of BPH-1, LapC4
and Du145 in passing through a layer of Matrigel in vitro in
comparison to uninfected controls at 24 hours after infection.
Figure 4B shows that a complete blockade of invasiveness was
observed for SS1 infected BPH-1 and LapC4 (top and middle
panels). The invasiveness of Du145 cells was also reduced;
however, even cells in the control group were not capable of
invading through matrigel with a comparable intensity as the other
tested cells (bottom panel). Therefore, the SS1 virus is capable of
specifically targeting prostate cells with increased Ras signaling
and thereby specifically inducing loss of viability and invasiveness
in these cells. Both of these biological effects on the host cell can
play an important role in the translational potentials of SS1 for
targeting cancer cells.
Infection with SS1 enhances cell death, alters cell cycle
progression and reduces colony formation of prostate
cancer cells
In order to investigate the mechanism of cell death upon
exposure to SS1, we evaluated the occurrence of necrosis and
apoptosis in these cells once exposed to SS1 virus. Figure 4C shows
a significant (p,0.05) increase in both necrosis and apoptosis upon
infection of LnCap and LapC4. Although all other cells showed
apoptosis and necrosis, the increase observed in the case of cancer
cells with elevated Ras signaling (LapC4 and LnCap) was
remarkably greater than other cells. Interestingly, PrECs seem to
mainly undergo apoptosis upon infection with SS1.
In next step we evaluated the outcome of exposure to SS1 virus
on cell cycle progression of high and low Ras signaling cells and
compared these results with the effects of parental HSV-1
infection. Figure 4D shows the results of cell cycle analysis after
24 hours of exposure to MOI,1 of SS1 or HSV-1 virus as well as
data obtained from uninfected controls. In LapC4 cells SS1
SS1 Virus: A Hunter for Ras
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the G1-phase of the cell cycle (p,0.05). HSV-1, however, did not
induce such effects in these cells. In the case of Du145 cells, a
reverse phenomenon was observed as the fraction of G1 cells was
decreased, while cells in S-phase increased.
Although the functional analysis of these data requires further
evaluation, it is possible to interpret them in a preliminary manner
in light of our understanding of the role of Ras signaling in the
passage of cells from G0 to S-phase and the impact of herpetic
infection on this passage. Ras signaling elevates levels of cyclin-D1,
which is responsible for facilitating advancement through G1-
phase. Ras signaling influences the transcription, translation and
protein stability of cyclin D1. An increase in p21 levels results from
direct effects on transcription and indirect effects through cyclin
D1 on protein stability. Cyclin D1 and p21 then drive the
formation of active cyclin-D1–CDK4 (cyclin-dependent kinase-4)
and cyclin-D1–CDK6 complexes, which promote cell-cycle
progression by phosphorylating retinoblastoma (RB) proteins
[22]. The Ras-Raf-ERK pathway has been shown to be required
for expression of cyclin D1 and its assembly into a complex with
CDK4 or CDK6. On the other hand, HSV-1 infection has been
shown to prevent infected cells from progression from G1 into S-
phase diminishing the normal increase in Cyclin D1 and D3
[23,24]. SS1 virus, with its replication dependency on Ras
Figure 3. SS1 virus preferentially infects cells with increased Ras/ELK signaling. Morphological studies of SS1-infected cells (MOI,1) show
rounding and clumping (signs of herpetic infection) in cancer cells with elevated Ras/ELK signaling (LnCap and LapC4) as well as PrEC and BPH-1 cells
as compared with Du145 and PC3 cells at 24-48 hours post-infection (MOI,1). (A) The titration of viral progeny at 24–48 hours post-infection
(MOI,1) revealed enhanced levels for LnCap and LapC4 as well as PrEC and BPH-1 as compared with Du145 and PC3 cells. In case of PrEC and BPH-1
cells titrations maximize at 24 hours. (B) Immunofluorescent (IF) studies for glycoprotein C (gC, a marker for herpetic infection) revealed enhanced
expression for LapC4 (high Ras) as compared to Du145 (low Ras) cells upon infection with SS1 (second row). Expression of this marker in these two
cell lines was at much closer levels once these cells were infected with parental HSV-1. Top panel represents IF intensity for each panel versus number
of captured events in each field. Third row represents the DAPI staining of related panels. Bottom panel shows staining of uninfected Du145 cells and
the background Texas-red and DAPI staining. (C) The expression of SS1 proteins was investigated by western blotting on lysates from infected and
control cells using an anti-body raised against all HSV-1 antigens. Higher and more comprehensive levels of SS1 protein synthesis was observed for
LnCap, LapC4, PrEC and BPH-1 as compared to Du145 and PC3 cells. Controls (uninfected cells) show no bands proving the specificity of antibody for
viral proteins. Lower panel shows a significant decrease in the expression of SS1 proteins in infected LnCap cells upon exposure to inhibitors of Ras
(FTI-277 at 20 mM), MEK (PD98059 at 25 mM) and ELK (Chromomycin A at 10 mM) but not the vehicle (DMSO). A lower level of inhibition was observed
for inhibitor of EGFR, AG1478 (0.5 mM). Cells were incubated with these inhibitors overnight and then exposed to SS1 while inhibitors existed in the
media.
doi:10.1371/journal.pone.0006514.g003
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produces ICP4 (a protein shown to be required for viral-induced
G1/S blockade) under direct influence from Ras/ERK/ELK
pathway. In the case of such low Ras signaling cells as Du145, the
SS1 virus is less effective in blocking G1/S transition resulting in
an increase in the S fraction. Therefore, the passage through G1/S
Figure 4. The effects of SS1 infection on the phenotype of prostate cells. The proliferation rate of prostate cells is decreased upon exposure
to SS1 virus (MOI,1) with lower levels observed in case of prostate cancer cells with high Ras signaling (LnCap and LapC4) and PrEC and BPH-1 cells
as compared to Du145 and PC3 cells (low Ras cells). (A) Invasiveness of prostate cancer cells LapC4 and Du145 as well as BPH-1 cells were decreased
after 24 hours of exposure to SS1 virus in a significant manner. The decrease in invasiveness was more prominent for cells with elevated Ras signaling
(LapC4 and BPH-1) as compared with Du145. Control Du145 cells were much less invasive than other cells. (B) Increase in necrosis and apoptosis is
observed upon exposure of prostate cells to SS1 virus. The induction in necrosis/apoptosis is remarkably greater in LnCap and LapC4 cells. (C) The
progression of cell cycle is altered upon exposure of prostate cancer cells to SS1 virus. In case of a high Ras cell (LapC4) an increase in G1 and
decrease in S and G2 was observed upon infection with SS1 as compared with parental virus infected and control cells. Du145 (a low Ras cell),
however, showed a passage through G1 but significant enhancement of S1 fraction. Left panels represent captured data plotted as fluorescence
intensity (FL2-H channel) versus cell number for different phases of cell cycle. The right panel portrays these data as percentage of control (non-
infected cells) for SS1 or HSV-1 infected cells. (D) Colony formation capability of LapC4 and Du145 cells was also significantly reduced upon infection
with SS1. Upper panels show formation of colonies for a range of number of inoculated infected cells. The lower panels show average number of
colonies per microscopy field for SS1-infected and control groups. The colony forming capability of Du145 cells were less inhibited as compared to
LapC4 cells. (E) The mechanism of SS1 action is illustrated in this figure. Activation of Ras signaling pathway stimulates a signal through Raf/MEK/ERK
pathway inducing phosphorylation of ELK. Stimulation of SRE elements by a complex including P-ELK results in expression of ICP4 and replication of
SS1 which eventually destroys the cell via infection.
doi:10.1371/journal.pone.0006514.g004
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to HSV-1-infected cells due to the lesser infectibility of Du145 cells
by the SS1 virus.
Finally, the capabilities of LapC4 and Du145 cells to form
colonies upon infection with SS1 (MOI,0.5) virus was evaluated.
Figure 4E shows complete abrogation of the capabilities of LapC4
cell lines after three weeks of inoculation of cells for this assay. In
case of Du145 cells, a decrease was observed in the number of
colonies upon exposure to SS1 however a complete blockade was
not observed. Reduction in the colony formation capabilities of
prostate cancer cells is another indicator of change in the
malignant phenotype of prostate cancer cells upon exposure to
the SS1 virus.
Concluding Remarks
Figure 4F portrays the overall Ras-dependent mechanism for
SS1 replication. Ras signaling can be activated by a variety of up-
stream events such as binding of growth factors to the receptor
tyrosine kinases (RTKs) or pro-oncogenic activation of Ras or
signaling via down-stream molecules such as Raf or ERK.
Activation of Ras signaling then results in activation of ELK. As
a consequence of elevated levels of Ras signaling, therefore, the
SS1 virus replicates efficiently due to the existence of ELK binding
sites in the promoter region of its recombinant alpha-4 gene.
Correlation between Ras signaling and SS1 replication and
induction of cytotoxic effects such as loss of viability and induction
of necrosis and apoptosis was shown in our work. Additionally,
invasiveness was seen to be blocked as early as 24 hours post-
infection with SS1. While PrECs used in our studies also showed
elevated levels of ELK activation, their signaling may not reflect
the situation in tumor tissues based on the data shown in our work
and others [25,26]. Also, once exposed to SS1, high Ras prostate
cancer cells had an increase in the G1 fraction of cells and lost
their colony formation capabilities. Although the interaction
between two complex biological systems (virus and host) is a
function of multi-factorial events, the linkage of expression of ICP4
to the Ras pathway seems to direct the overall dynamics of this
relationship, which is significantly influenced by Ras signaling.
Further evaluation of the effects of signal-smart viruses on host cell
biology improves our understanding about the mechanism of the
virus-host relationship and opens new horizons in using these
biological agents in detection and targeting cancer cells with
enhanced specificity and efficiency.
Materials and Methods
Cells, media, chemicals and viruses
African green monkey kidney cells (Vero) and E5 (Vero cells
transfected with HSV-1 alpha-4 gene) cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% Fetal calf serum. The prostate cancer cell lines were
grown in BPH-1 (RPMI 1640+5%FBS+1%A.B), Du145
(DMEM+10%FBS+1% AB), LapC4 (IMDM+10%FBS+1% AB),
LnCap (RPMI-1640+10%FBS+1% AB) and PC3 (Hams F-
12K+10%FBS+1%AB). HSV-1(F) virus was a gift from Dr.
Bernard Roizman (University of Chicago). HSV-1 mutant d120,
containing a 4.1-kb deletion in both copies of the ICP4 gene, and
the complementary cell line E5 [27,28] were kindly provided by
Robert L. Martuza (Harvard Medical School, Boston, MA). The
stock of mutant d120 virus was prepared in E5 cells. Every stock of
d120 virus was titrated by infecting 10
6 PFU of viruses from the
stock in Vero monolayer, harvesting the culture medium, and then
determining the existence of any infectious progeny by plaque
assay on Vero cells.
Plasmid construction
Using a sense primer, 59-CTCACAGCTAGCTTGGG-
TAACGCCAGGGTTTTC-39 and antisense primer, 5-9ACTG-
TATAGATCTCGCCCCTCGAATAAACAACGC-39, we am-
plified the ICP4 gene by PCR from DNA template, pGH108.
The PCR product (4.2 KB) was then inserted into the vector,
pCR-Blunt-TOPO (Invitrogen, catalog no:K2800-20). An EcoRI-
ICP4-EcoRI fragment from the TOPO clone was then isolated
and subcloned into the vector, pIRES/DsRed express (Clontech,
catalog no:632463), between CMV and IRES/DsRED genes at
EcoRI single site. The construct was designated as pIID. In next
step, we amplified part of human TK gene from DNA template,
pHSV106, by using primers, 59-ATCGCTAGCTCCAAGACT-
GACACATT-39 and 59-ATGCTAGCACTAGTACCGGTAG-
TACTGCTGAGGTGGGCTTTGGACGTCTT-39. The PCR
product was then cloned into the vector, pCRII-TOPO (Invitro-
gen, Cat. No. K4600-01). A NheI-TK-NheI fragment, TK59,
from the TOPO-clone was then subcloned into the plasmid, pIID,
in front of ICP4 gene. The construct was designated as pTIID.
The 39 segment of the viral TK gene was also amplified from
pHSV106 by primers 59-GGGTTAACATTTAAAT-
CAGGTCGCCGTTGGGGGCCA-39 &5 9-GGGTTAA-
CAAATGAGTCTTCGGACCTC-39 and subcloned into the
pCRII-TOPO as mentioned above. The HpaI-TK-HpaI frag-
ment, TK39, was cloned into the plasmid, pTIID, on the 39of the
IRES/DsREd genes at its HpaI single site. This construct was
designated as pTIIDT. As mentioned above, we did TOPO-Clone
for the SRE promoter from the template DNA, pSRE-Luc, by
primers, 59-CCTCAGCTGTCTGGATCCAAGCTAGGA-39
and 59-GACTAGTATGCCAAGCTGGAA TTCGAG-39.A
BbvCI-SRE-SpeI fragment was cloned into the plasmid, pTIIDT,
between TK 59 and ICP4 gene. The construct was designated
pTSIIDT and was eventually used for transfecting E5 cells. All the
fragments from PCR TOPO clones were sequenced.
Generation of SS1
E5 cells were seeded onto 150 mm dish to grow overnight to
80%–90% confluency.
Transfection of pTSIID was performed by using Lipofectami-
neTM2000 (Invitrogen, CA) according to the manufacturer’s
protocol. After transfected E5 cells were incubated at 37uC and
5% CO2 for 72 h, the supernatant was discarded and transfected
cells were infected with d120 virus by adding 10 ml diluted d120
preparation for 1.5 h infection incubation (with gentle rocking).
Fresh medium was then added and incubation continued for three
days. The virus was then harvested by scraping cells off the flask
surface in combination with supernatant followed by three cycles
of freeze-thaw and supplementation with 10% autoclaved non-fat
milk for increased stability. Recombinant viral isolates were
purified by three rounds of plaque purification on Vero cells. Total
and viral genomic DNA was isolated for each recombinant virus
isolate (six independent viral isolates numbered 1–6 are shown in
figure 1B). Using PCR reactions by different primer pairs, the
genomic composition of these recombinant virus isolated were
identified with established methods [20]. Isolate number 3 was
chosen for expansion and completion of experiments in this
manuscript.
Nuclear extraction and SRE activation Luminex assay
Nuclear extract was made by a nuclear extraction kit from
Marligen Bioscience (cat. #11906-100). Briefly, cells were cultured
in a T-175 flask to about 90% confluency and washed twice with
ice-cold PBS, collected with a cell scraper in PBS and transferred
to a 15 ml conical tube. The cells were then centrifuged 5 minutes
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complete hypotonic lysis buffer and incubated on ice for 10
minutes. In next step 25 ml of detergent solution was added,
vortexed for 5 seconds and spun for 5 minutes at 3000 rpm at 4uC.
The supernatant was then discarded and pellet was washed twice
with 500 ml complete wash solution. 50 ml of complete Extraction
Buffer1 and 50 ul of complete extraction buffer 2 were then added
and the mixture was then incubated on ice for 30 minutes. The
nuclear extract was clarified by centrifugation and stored at
280uC until use. Three mg nuclear extract was used for SRE
transcription assay by a kit from Marligen Bioscience (catalog #
11944-096 and 11906-100) according to manufacturer’s instruc-
tions. Briefly nuclear extracts were incubated with a mixture of
biotinylated DNA binding probes. During the incubation, the
active transcription factor complexes in the sample were bound to
their specific probes, whereas unbound probes were removed
utilizing Marligen’s patented digestion step. The remaining probes
were incubated with a mixture of different fluorescently dyed
xMAPH beads. Each different xMAPH bead is coupled with a
unique probe that recognizes a specific DNA binding probe so that
the probes hybridize to their specific bead region. Following
hybridization, the samples were incubated with streptavidin-
phycoerythrin (SAPE) and read on the Luminex
TM instrument,
which detect the specific transcription factors activated in the
sample by their unique bead region and quantified by the intensity
of the SAPE signal.
SDS-PAGE and Western blot analysis
Different cells were lysed with a single detergent lysis buffer
[50 mM Tris (pH 8.0), 150 mM NaCl, 0.02% sodium azide,
100 mg/ml phenylmethy-sulfonyl fluoride, 1 mg/ml aprotinin, and
1% Triton X-100], normalized for the amount of total protein and
subjected to SDS-PAGE using BioRad mini-cell protein-II system
(using pre-cast 10% discontinuous gels) followed by electroblotting
onto nitrocellulose paper. The membrane was then washed and
incubated with a primary rabbit antibody against all HSV-1
antigens (Dako, CA), followed by the horseradish peroxidase
(HRP)-conjugated secondary antibody. After extensive washing,
the blot was exposed to Lumigel detection solution and subjected
to autoradiography.
Exposure to inhibitors of Ras signaling
Uninfected cells were exposed to Ras and its down-stream
specific inhibitors overnight at the following concentrations:
AG1478 at 0.5 mM, FTI-276 at 5 nM, PD98059 at 20 mM and
Chromomycin A at 500 nM and then exposed to the virus.
Chemicals were obtained from Calbiochem (CA).
Non-radioactive affinity pull-down assay for ERK
activation
Non-radioactive ERK pathway activation assay were performed
in accordance to the manufacturer’s (Cell Signaling, MA)
instructions. Briefly, cells grown in 10 cm tissue culture dishes
were lysed at 75–80% confluency with 300 ul of cell lysis buffer.
Immobilized antibody-against phospho-ERK1/2 bead slurry
capable of binding to the phosphorylated forms of ERK was then
added to 200 mg of total cell protein in 200 ml of cell lysis buffer.
The mixture was incubated with gentle rocking overnight at 4uC
then collected, washed and introduced to an in-vitro kinase reaction
in presence of ATP and ELK, the substrate for phospho-ERK.
The levels of phosphorylated ELK was then assayed by western
blotting using antibodies directed against phosphorylated (active)
form of this transcription factor.
Plaque (viral progeny) titration assay
Plaque titration was performed with the purpose of evaluating
the yield of progeny virus at 24–48 hours post-infection. Briefly,
the supernatant from infected cells were serially diluted from 1/10
to 1/10
8. A volume of 300 ml from each dilution was added to
duplicate wells (of 6-well plates) containing Vero cells at ,75%
confluency after removal of the existing media and rinsing the cells
with phosphate the buffered saline (PBS). Cells were then
incubated at 37uC until development of cytopathic effects in the
form of plaques which usually occurs within 2–3 days. At this
point, a monolayer was fixed with methanol and stained with
Giemsa solution for 10 minutes. The number of clear plaques was
then determined by calculating the average of number of plaques/
well for each dilution and the volume used to infect each well.
Immunofluorescent analysis of Herpes infection and
analysis of antibody staining
Cells were grown in 8-well slide chambers (Falcon) and infected
with HSV-1 (strain F) or SS1 or mock-infected. At different times
post-infection, cells were fixed in acetone (100%) for 10 min and
then left at room temperature to dry before incubation with a
fluorescin-labeled mouse monoclonal antibody against HSV-1 gC
antigen (labvision) for 30 min at 37uC. The slides were washed
with distilled water, dried, and mounted in 90% glycerol
containing 0.1% phenylenediamine, and viewed with a Zeiss
Axiophot microscope on which a Carl Zeiss camera was mounted.
Pictures were captured by an attached computer and processed
with appropriate software. All images for phospho-ELK expres-
sion were analyzed and quantified by Image J. software (by
National Institute of Health, NIH) which reflects brown nuclei
staining due to the expression of phospho-ELK.
Cell Invasion assay
In order to evaluate cell invasiveness, a commercial kit was used
(BD Biosciences, CA). Briefly, cells (50,000 control or test cells)
were introduced into Matrigel-coated inserts fitting 24 well plates.
As cells invaded through the layer of Matrigel, the fraction of
invaded cells were detected by staining them with crystal violet
and quantifying them by spectroscopy. Invaded cells were fixed
with 5% paraformaldehyde and stained with a 5%-solution of
crystal violet and then photographed to obtain a visual
representation of their density. The cells were then solublized in
a 3%-detergent (NP40) solution, and the absorbance was
measured by spectrophotometry at 590 nm.
Cell proliferation assay
The cell proliferation assay was performed using a kit (Millipore,
CA) according to the manufacturer’s instructions. The assay is
based on the cleavage of the tetrazolium salt WST-1 to formazan
by cellular mitochondrial dehydrogenases. Expansion in the
number of viable cells results in an increase in the overall activity
of the mitochondrial dehydrogenases resulting in an increase in the
amount of formazan dye formed. Briefly, 10
4 cells/well were
seeded in a 96-well microplate in volume of 100 mL/well. At
different times, 10 mL WST-1/ECS solution was added to each
well. The plates were incubated for 4 hours in standard culture
conditions. The plates were then shaken thoroughly for one
minute and absorbance was measured at 480 nm.
Necrosis and apoptosis assay
Cells were seeded in a 96-well plate (plate-1) at a density of
1610
4 cells/well. After 24 hours cells were infected with SS-1 at
MOI,0.5 for 48 hr. The Plate-1 was centrifuged at 200 g for
SS1 Virus: A Hunter for Ras
PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e651410 min. Supernatant was introduced into another 96-well plate
(plate-2) and kept it in 4uC. To lyse the cells in plate-1, 200 ml lysis
buffer/well (Roche, Cat. No. 11774425001) was added. After
incubation for 30 min at room temperature (RT), then plate-1 was
centrifuged at 200 g for 10 min. 20 ml of lysates from plate-1 and
20 ml of supernatant from plate-2 each were introduced into the
streptavidin coated microplates in triplicate for each sample. After
80 ml of the immunoreagent was added into each well, the
microplate was covered and incubated on a shaker at 250 rpm for
2 hours at RT. In next step each well was rinsed 3 times with
250 ml incubation buffer and 100 ml ABTS solution was added
and shaked 20 min at 250 rpm for color development. 100 ml
ANTS stop solution was then added to each well and the emission
was measured at 405 nm.
Cell cycle assay
10
6 cells for each cell line were pelleted and washed twice by
CycleTEST PLUS buffer solution (BECTON DICKINSON, Cat.
No. 340242). The cell pellet was then resuspended in 1 ml of the
same buffer solution. To stain the cells, 250 ml Solution A and
200 ml solution B were added and incubated 10 minutes at RT.
200 ml of cold solution C was added in the last and incubated 10
minutes at 4uC. The cells were filtered through a 35-mm cell
strainer cap into a 12675-mm tube. The samples were kept the
tube in dark and analyzed by FACSort flow cytometer.
Colony formation assay
For colony formation assays, cells were infected with virus
overnight with MOI,1. Following infection, cells were trypsin-
ized, counted and plated in triplicates at different concentration
100,200 –1000cells per well for each cell line in a 6 well plate and
allowed to grow for 10–14 days changing media every 2 days.
After 10–14 days when cells grew into visible colonies, plates were
washed twice with PBS and were stained with crystal violet with
methanol overnight. Next day plates were washed with water few
times till the background was clear and number of colonies in
different microscopic fields were counted.
Statistical Analysis
Results are reported as means6standard deviation (SD).
Student’s t test was used to analyze statistical differences between
groups. Alpha (a . level was set at 0.05).
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